Philip G Janicak

Summary

Affiliation: Rush University Medical Center
Country: USA

Publications

  1. doi request reprint Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study
    Philip G Janicak
    Department of Psychiatry, Rush University Medical Center, Chicago, Illinois 60612, USA
    Brain Stimul 3:187-99. 2010
  2. ncbi request reprint Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment
    Philip G Janicak
    Department of Psychiatry, Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Psychiatry 69:222-32. 2008
  3. ncbi request reprint Vagus nerve stimulation for severe depression
    Jeffrey Rado
    Department of Psychiatry, Rush University, Chicago, IL 60612, USA
    J Psychosoc Nurs Ment Health Serv 45:43-51. 2007
  4. ncbi request reprint The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies
    Philip G Janicak
    Department of Psychiatry, Rush University Medical Center, Chicago, Illinoise 60612, USA
    J Clin Psychiatry 70:25-35. 2009
  5. doi request reprint Quetiapine monotherapy for bipolar depression
    Philip G Janicak
    Psychiatric Clinical Research Center, Rush University, 2150 West Harrison Street, Suite 253, Chicago, IL 60612, USA
    Expert Opin Pharmacother 12:1643-51. 2011
  6. pmc Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder
    Mani N Pavuluri
    Department of Psychiatry, Institute for Juvenile Research, University of Illinois at Chicago, USA
    Bipolar Disord 12:593-605. 2010
  7. pmc An fMRI study of visual attention and sensorimotor function before and after antipsychotic treatment in first-episode schizophrenia
    Sarah K Keedy
    Center for Cognitive Medicine, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL 60612, United States
    Psychiatry Res 172:16-23. 2009
  8. ncbi request reprint A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder
    Mani N Pavuluri
    Pediatric Bipolar Research Program, Department of Psychiatry, University of Illinois at Chicago UIC, 912 South Wood Street, Chicago, IL 60612, USA
    J Child Adolesc Psychopharmacol 16:336-50. 2006
  9. ncbi request reprint Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression
    Brian Martis
    Department of Psychiatry, Psychiatric Clinical Research Center and Center for Cognitive Medicine, University of Illinois at Chicago, 912 South Wood Street Suite 137 MC 913, Chicago, IL 60612, USA
    Clin Neurophysiol 114:1125-32. 2003
  10. ncbi request reprint Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania
    Mani N Pavuluri
    Pediatric Bipolar Research Program, Department of Psychiatry, University of Illinois at Chicago UIC, Chicago, IL 60612, USA
    J Affect Disord 82:S103-11. 2004

Detail Information

Publications26

  1. doi request reprint Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study
    Philip G Janicak
    Department of Psychiatry, Rush University Medical Center, Chicago, Illinois 60612, USA
    Brain Stimul 3:187-99. 2010
    ..Although transcranial magnetic stimulation (TMS) can be an effective acute antidepressant treatment, few studies systematically examine persistence of benefit...
  2. ncbi request reprint Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment
    Philip G Janicak
    Department of Psychiatry, Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Psychiatry 69:222-32. 2008
    ..We examined the acute efficacy of TMS in a randomized sham-controlled trial, under open-label conditions, and its durability of benefit...
  3. ncbi request reprint Vagus nerve stimulation for severe depression
    Jeffrey Rado
    Department of Psychiatry, Rush University, Chicago, IL 60612, USA
    J Psychosoc Nurs Ment Health Serv 45:43-51. 2007
    ..It is important for psychiatric nurses to understand the evidence base for and how VNS is used in treatment so they may enhance care of patients with treatment-resistant depression...
  4. ncbi request reprint The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies
    Philip G Janicak
    Department of Psychiatry, Rush University Medical Center, Chicago, Illinoise 60612, USA
    J Clin Psychiatry 70:25-35. 2009
    ..To evaluate the efficacy of aripiprazole across a range of symptoms-positive, negative, disorganized thought, depression/anxiety, and hostility-in schizophrenia and schizoaffective disorder...
  5. doi request reprint Quetiapine monotherapy for bipolar depression
    Philip G Janicak
    Psychiatric Clinical Research Center, Rush University, 2150 West Harrison Street, Suite 253, Chicago, IL 60612, USA
    Expert Opin Pharmacother 12:1643-51. 2011
    ..Finally, the evidence base for pharmacotherapy of bipolar depression is much smaller than for unipolar depression or hypomania/mania...
  6. pmc Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder
    Mani N Pavuluri
    Department of Psychiatry, Institute for Juvenile Research, University of Illinois at Chicago, USA
    Bipolar Disord 12:593-605. 2010
    ..To determine the relative effects of risperidone and divalproex in pediatric mania...
  7. pmc An fMRI study of visual attention and sensorimotor function before and after antipsychotic treatment in first-episode schizophrenia
    Sarah K Keedy
    Center for Cognitive Medicine, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL 60612, United States
    Psychiatry Res 172:16-23. 2009
    ....
  8. ncbi request reprint A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder
    Mani N Pavuluri
    Pediatric Bipolar Research Program, Department of Psychiatry, University of Illinois at Chicago UIC, 912 South Wood Street, Chicago, IL 60612, USA
    J Child Adolesc Psychopharmacol 16:336-50. 2006
    ..The aim of this study was to assess the safety and efficacy of risperidone augmentation of lithium in preschool-onset bipolar disorder (BD) among youth who insufficiently respond to lithium monotherapy...
  9. ncbi request reprint Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression
    Brian Martis
    Department of Psychiatry, Psychiatric Clinical Research Center and Center for Cognitive Medicine, University of Illinois at Chicago, 912 South Wood Street Suite 137 MC 913, Chicago, IL 60612, USA
    Clin Neurophysiol 114:1125-32. 2003
    ..We evaluated neurocognitive effects of a 1-4 week course (mean 3 weeks) of rTMS using an aggressive set of parameters, in 15 severely depressed subjects...
  10. ncbi request reprint Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania
    Mani N Pavuluri
    Pediatric Bipolar Research Program, Department of Psychiatry, University of Illinois at Chicago UIC, Chicago, IL 60612, USA
    J Affect Disord 82:S103-11. 2004
    ....
  11. ncbi request reprint Divalproex sodium for pediatric mixed mania: a 6-month prospective trial
    Mani N Pavuluri
    Pediatric Mood Disorders Research Program, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL 60612, USA
    Bipolar Disord 7:266-73. 2005
    ..This prospective 6-month open trial examined the effectiveness and safety of divalproex sodium (DVPX) in pediatric mixed mania...
  12. ncbi request reprint Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial
    H Brent Solvason
    Department of Psychiatry, University of Pennsylvania, 3535 Market Street, Philadelphia, PA 19014, USA
    Biol Psychiatry 62:1208-16. 2007
    ..We tested whether transcranial magnetic stimulation (TMS) over the left dorsolateral prefrontal cortex (DLPFC) is effective and safe in the acute treatment of major depression...
  13. pmc Aripiprazole for late-life schizophrenia
    Jeffrey Rado
    Psychiatric Clinical Research Center, Rush University Medical Center, Chicago, IL 60612, USA
    Clin Interv Aging 5:253-8. 2010
    ..With this background in mind, we review diagnostic and treatment-related issues specific to elderly patients suffering from schizophrenia and other psychotic conditions, focusing on the potential role of aripiprazole...
  14. ncbi request reprint The role of psychopharmacotherapy in improving the long-term outcome of schizophrenia
    Danesh A Alam
    University of Illinois at Chicago, Chicago, IL, USA
    Essent Psychopharmacol 6:127-40. 2005
    ....
  15. doi request reprint Pharmacological and clinical profile of recently approved second-generation antipsychotics: implications for treatment of schizophrenia in older patients
    Jeffrey Rado
    Psychiatric Clinical Research Center, Rush University Medical Center, Chicago, IL 60612, USA
    Drugs Aging 29:783-91. 2012
    ..While there is limited data to support their safety, tolerability and efficacy in older patients with schizophrenia, each has unique characteristics that should be considered when used in this population...
  16. doi request reprint Quetiapine for the treatment of acute bipolar mania, mixed episodes and maintenance therapy
    Philip G Janicak
    Rush University Medical Center, Psychiatric Research Clinical Center, 2150 West Harrison, Chicago, IL 60612, USA
    Expert Opin Pharmacother 13:1645-52. 2012
    ..First-line pharmacological approaches usually involve lithium, anticonvulsants and antipsychotics. Over the past fifteen years, several second-generation antipsychotics have demonstrated benefits for various phases of this disorder...
  17. ncbi request reprint A pharmacotherapy algorithm for stabilization and maintenance of pediatric bipolar disorder
    Mani N Pavuluri
    Pediatric Mood Disorders Clinic, Bipolar Research Program, Department of Psychiatry, University of Illinois at Chicago, 60612 7347, USA
    J Am Acad Child Adolesc Psychiatry 43:859-67. 2004
    ..To assess the feasibility and effectiveness of an evidence-based pharmacotherapy algorithm in the treatment of pediatric bipolar disorder...
  18. doi request reprint Iloperidone for schizophrenia
    Jeffrey Rado
    Psychiatric Clinical Research Center, Rush University Medical Center, Chicago, IL 60612, USA
    Expert Opin Pharmacother 11:2087-93. 2010
    ..Also, no antipsychotic adequately benefits most patients with this disorder. Finally, the safety and tolerability of each antipsychotic frequently dictate the choice of agent...
  19. ncbi request reprint Elimination of 7-aminoclonazepam in urine after a single dose of clonazepam
    Adam Negrusz
    Department of Biopharmaceutical Sciences M C 865, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA
    Anal Bioanal Chem 376:1198-204. 2003
    ..The range of concentrations detected was from 73.0 pg x mL(-1) to 183.2 ng x mL(-1). CLO was not detected in any of the samples...
  20. doi request reprint Hospitalization rates before and after initiation of paliperidone ER in patients with schizophrenia: results from open-label extensions of the US double-blind trials
    Philip G Janicak
    Department of Psychiatry, Rush University Medical Center, Chicago, IL, USA
    Curr Med Res Opin 24:1807-15. 2008
    ....
  21. ncbi request reprint Serotonin receptors in platelets of bipolar and schizoaffective patients: effect of lithium treatment
    Ghanshyam N Pandey
    Psychiatric Institute, Department of Psychiatry, University of Illinois at Chicago, 1601 West Taylor Street, Chicago, IL 60612, USA
    Psychopharmacology (Berl) 170:115-23. 2003
    ..However, the role of 5HT2A receptors in bipolar disorders and in the mechanism of action of lithium is unclear...
  22. ncbi request reprint The behavioral and cognitive effects of two benzodiazepines associated with drug-facilitated sexual assault
    Sheila M Dowd
    Department of Psychiatry, College of Medicine, University of Illinois at Chicago, USA
    J Forensic Sci 47:1101-7. 2002
    ..CLO affected memory and attention throughout the study (6 h), and psychomotor performance was decreased 2 h post ingestion. In both studies, subjects were disinhibited and did not perceive their own impairment...
  23. ncbi request reprint Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: preliminary results of a randomized trial
    Philip G Janicak
    Department of Psychiatry, University of Illinois at Chicago, 1601 W Taylor Street, Chicago, IL 60612, USA
    Biol Psychiatry 51:659-67. 2002
    ..Repetitive transcranial magnetic stimulation (rTMS) has been reported to benefit depression. We compared rTMS to electroconvulsive therapy (ECT) in severely ill, depressed patients...
  24. ncbi request reprint Repetitive transcranial magnetic stimulation versus electroconvulsive therapy: efficacy of treatment in nonpsychotic patients with depression
    Philip G Janicak
    Am J Psychiatry 164:1118; author reply 1118-9. 2007
  25. ncbi request reprint An interview with Philip G. Janicak, MD: Neuromodulation by Norman Sussman, MD
    Philip G Janicak
    CNS Spectr 13:370-4. 2008
  26. ncbi request reprint Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial
    David H Avery
    Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Harborview Medical Center, Seattle, WA 98104 2499, USA
    J Clin Psychiatry 69:441-51. 2008
    ....